tiprankstipranks
Sinovac Biotech (SVA)
NASDAQ:SVA
US Market

Sinovac Biotech (SVA) Balance Sheet

113 Followers

Sinovac Biotech Balance Sheet

Sinovac Biotech's total assets for Q4 2023 were $13.66B, a decrease of -3.23% from the previous quarter. SVA total liabilities were $1.64B for the fiscal quarter, a 16.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 13.66B$ 14.11B$ 16.75B$ 1.90B$ 452.30M
Total Liabilities
$ 1.64B$ 1.40B$ 2.87B$ 781.20M$ 100.10M
Total Equity Gross Minority
$ 12.02B$ 12.71B$ 13.88B$ 1.12B$ 352.19M
Total Capitalization
$ 8.89B$ 9.47B$ 9.98B$ 754.76M$ 295.45M
Preferred Stock Equity
---$ 15.00K$ 15.00K
Capital Lease Obligations
---$ 89.00M$ 6.29M
Currency in USD

Sinovac Biotech Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis